Work productivity in rhinitis using cell phones: The MASK pilot study

J. Bousquet; M. Bewick; S. Arnavielhe; E. Mathieu-Dupas; R. Murray; A. Bedbrook; D. P. Caimmi; O. Vandenplas; P. W. Hellings; C. Bachert; J. M. Anto; K. C. Bergmann; C. Bindslev-Jensen; S. Bosnic-Anticevich; J. Bouchard; G. W. Canonica; N. H. Chavannes; A. A. Cruz; R. Dahl; P. Demoly; G. de Vries; P. Devillier; A. Fink-Wagner; W. J. Fokkens; J. Fonseca; N. A. Guldemond; T. Haahtela; B. Hellqvist-Dahl; J. Just; T. Keil; L. Klimek; M. L. Kowalski; P. Kuna; V. Kvedariene; D. Laune; D. Larenas-Linnemann; J. Mullol; A. M. Pereira; P. Carreiro-Martins; E. Melén; M. Morais-Almeida; L. Nogueira-Silva; R. E. O'Hehir; N. G. Papadopoulos; G. Passalacqua; F. Portejoie; D. Price; D. Ryan; B. Samolinski; A. Sheikh; F. E. R. Simons; O. Spranger; A. Todo Bom; P. V. Tomazic; M. Triggiani; A. Valero; E. Valovirta; A. Valiulis; M. van Eerd; M. Wickman; I. Young; T. Zuberbier

doi:https://doi.org/10.1111/all.13177

Work productivity in rhinitis using cell phones: The MASK pilot study

J. Bousquet, M. Bewick, S. Arnavielhe, E. Mathieu-Dupas, R. Murray, A. Bedbrook, D. P. Caimmi, O. Vandenplas, P. W. Hellings, C. Bachert, J. M. Anto, K. C. Bergmann, C. Bindslev-Jensen, S. Bosnic-Anticevich, J. Bouchard, G. W. Canonica, N. H. Chavannes, A. A. Cruz, R. Dahl, P. DemolyG. de Vries, P. Devillier, A. Fink-Wagner, W. J. Fokkens, J. Fonseca, N. A. Guldemond, T. Haahtela, B. Hellqvist-Dahl, J. Just, T. Keil, L. Klimek, M. L. Kowalski, P. Kuna, V. Kvedariene, D. Laune, D. Larenas-Linnemann, J. Mullol, A. M. Pereira, P. Carreiro-Martins, E. Melén, M. Morais-Almeida, L. Nogueira-Silva, R. E. O'Hehir, N. G. Papadopoulos, G. Passalacqua, F. Portejoie, D. Price, D. Ryan, B. Samolinski, A. Sheikh, F. E. R. Simons, O. Spranger, A. Todo Bom, P. V. Tomazic, M. Triggiani, A. Valero, E. Valovirta, A. Valiulis, M. van Eerd, M. Wickman, I. Young, T. Zuberbier

Research output: Contribution to journal › Article › Academic › peer-review

79 Citations (Scopus)

Abstract

Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) and asthma symptoms (VAS-asthma) as well as work (VAS-work). A combined nasal-ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAI: AS) in six EU countries. All consecutive users who completed the VAS-work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS-work. Symptoms of allergic rhinitis were controlled (VAS-global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS-work >50). There was a significant correlation between VAS-global calculated and VAS-work (Rho=0.83, P <0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS-work and WPAI: AS (Rho=0.53, P <0.0001). This pilot study provides not only proof-of-concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms

Original language	English
Pages (from-to)	1475-1484
Journal	Allergy
Volume	72
Issue number	10
Early online date	2017
DOIs	https://doi.org/10.1111/all.13177
Publication status	Published - 2017

Access to Document

https://doi.org/10.1111/all.13177

Cite this

Bousquet, J., Bewick, M., Arnavielhe, S., Mathieu-Dupas, E., Murray, R., Bedbrook, A., Caimmi, D. P., Vandenplas, O., Hellings, P. W., Bachert, C., Anto, J. M., Bergmann, K. C., Bindslev-Jensen, C., Bosnic-Anticevich, S., Bouchard, J., Canonica, G. W., Chavannes, N. H., Cruz, A. A., Dahl, R., ... Zuberbier, T. (2017). Work productivity in rhinitis using cell phones: The MASK pilot study. Allergy, 72(10), 1475-1484. https://doi.org/10.1111/all.13177

@article{53b58abb414a4addb35a543250c97ec9,

title = "Work productivity in rhinitis using cell phones: The MASK pilot study",

abstract = "Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) and asthma symptoms (VAS-asthma) as well as work (VAS-work). A combined nasal-ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAI: AS) in six EU countries. All consecutive users who completed the VAS-work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS-work. Symptoms of allergic rhinitis were controlled (VAS-global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS-work >50). There was a significant correlation between VAS-global calculated and VAS-work (Rho=0.83, P <0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS-work and WPAI: AS (Rho=0.53, P <0.0001). This pilot study provides not only proof-of-concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms",

author = "J. Bousquet and M. Bewick and S. Arnavielhe and E. Mathieu-Dupas and R. Murray and A. Bedbrook and Caimmi, {D. P.} and O. Vandenplas and Hellings, {P. W.} and C. Bachert and Anto, {J. M.} and Bergmann, {K. C.} and C. Bindslev-Jensen and S. Bosnic-Anticevich and J. Bouchard and Canonica, {G. W.} and Chavannes, {N. H.} and Cruz, {A. A.} and R. Dahl and P. Demoly and {de Vries}, G. and P. Devillier and A. Fink-Wagner and Fokkens, {W. J.} and J. Fonseca and Guldemond, {N. A.} and T. Haahtela and B. Hellqvist-Dahl and J. Just and T. Keil and L. Klimek and Kowalski, {M. L.} and P. Kuna and V. Kvedariene and D. Laune and D. Larenas-Linnemann and J. Mullol and Pereira, {A. M.} and P. Carreiro-Martins and E. Mel{\'e}n and M. Morais-Almeida and L. Nogueira-Silva and O'Hehir, {R. E.} and Papadopoulos, {N. G.} and G. Passalacqua and F. Portejoie and D. Price and D. Ryan and B. Samolinski and A. Sheikh and Simons, {F. E. R.} and O. Spranger and {Todo Bom}, A. and Tomazic, {P. V.} and M. Triggiani and A. Valero and E. Valovirta and A. Valiulis and {van Eerd}, M. and M. Wickman and I. Young and T. Zuberbier",

year = "2017",

doi = "https://doi.org/10.1111/all.13177",

language = "English",

volume = "72",

pages = "1475--1484",

journal = "Allergy",

issn = "0105-4538",

publisher = "Wiley-Blackwell",

number = "10",

}

Bousquet, J, Bewick, M, Arnavielhe, S, Mathieu-Dupas, E, Murray, R, Bedbrook, A, Caimmi, DP, Vandenplas, O, Hellings, PW, Bachert, C, Anto, JM, Bergmann, KC, Bindslev-Jensen, C, Bosnic-Anticevich, S, Bouchard, J, Canonica, GW, Chavannes, NH, Cruz, AA, Dahl, R, Demoly, P, de Vries, G, Devillier, P, Fink-Wagner, A, Fokkens, WJ, Fonseca, J, Guldemond, NA, Haahtela, T, Hellqvist-Dahl, B, Just, J, Keil, T, Klimek, L, Kowalski, ML, Kuna, P, Kvedariene, V, Laune, D, Larenas-Linnemann, D, Mullol, J, Pereira, AM, Carreiro-Martins, P, Melén, E, Morais-Almeida, M, Nogueira-Silva, L, O'Hehir, RE, Papadopoulos, NG, Passalacqua, G, Portejoie, F, Price, D, Ryan, D, Samolinski, B, Sheikh, A, Simons, FER, Spranger, O, Todo Bom, A, Tomazic, PV, Triggiani, M, Valero, A, Valovirta, E, Valiulis, A, van Eerd, M, Wickman, M, Young, I & Zuberbier, T 2017, 'Work productivity in rhinitis using cell phones: The MASK pilot study', Allergy, vol. 72, no. 10, pp. 1475-1484. https://doi.org/10.1111/all.13177

TY - JOUR

T1 - Work productivity in rhinitis using cell phones: The MASK pilot study

AU - Bousquet, J.

AU - Bewick, M.

AU - Arnavielhe, S.

AU - Mathieu-Dupas, E.

AU - Murray, R.

AU - Bedbrook, A.

AU - Caimmi, D. P.

AU - Vandenplas, O.

AU - Hellings, P. W.

AU - Bachert, C.

AU - Anto, J. M.

AU - Bergmann, K. C.

AU - Bindslev-Jensen, C.

AU - Bosnic-Anticevich, S.

AU - Bouchard, J.

AU - Canonica, G. W.

AU - Chavannes, N. H.

AU - Cruz, A. A.

AU - Dahl, R.

AU - Demoly, P.

AU - de Vries, G.

AU - Devillier, P.

AU - Fink-Wagner, A.

AU - Fokkens, W. J.

AU - Fonseca, J.

AU - Guldemond, N. A.

AU - Haahtela, T.

AU - Hellqvist-Dahl, B.

AU - Just, J.

AU - Keil, T.

AU - Klimek, L.

AU - Kowalski, M. L.

AU - Kuna, P.

AU - Kvedariene, V.

AU - Laune, D.

AU - Larenas-Linnemann, D.

AU - Mullol, J.

AU - Pereira, A. M.

AU - Carreiro-Martins, P.

AU - Melén, E.

AU - Morais-Almeida, M.

AU - Nogueira-Silva, L.

AU - O'Hehir, R. E.

AU - Papadopoulos, N. G.

AU - Passalacqua, G.

AU - Portejoie, F.

AU - Price, D.

AU - Ryan, D.

AU - Samolinski, B.

AU - Sheikh, A.

AU - Simons, F. E. R.

AU - Spranger, O.

AU - Todo Bom, A.

AU - Tomazic, P. V.

AU - Triggiani, M.

AU - Valero, A.

AU - Valovirta, E.

AU - Valiulis, A.

AU - van Eerd, M.

AU - Wickman, M.

AU - Young, I.

AU - Zuberbier, T.

PY - 2017

Y1 - 2017

N2 - Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) and asthma symptoms (VAS-asthma) as well as work (VAS-work). A combined nasal-ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAI: AS) in six EU countries. All consecutive users who completed the VAS-work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS-work. Symptoms of allergic rhinitis were controlled (VAS-global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS-work >50). There was a significant correlation between VAS-global calculated and VAS-work (Rho=0.83, P <0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS-work and WPAI: AS (Rho=0.53, P <0.0001). This pilot study provides not only proof-of-concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms

AB - Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) and asthma symptoms (VAS-asthma) as well as work (VAS-work). A combined nasal-ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAI: AS) in six EU countries. All consecutive users who completed the VAS-work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS-work. Symptoms of allergic rhinitis were controlled (VAS-global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS-work >50). There was a significant correlation between VAS-global calculated and VAS-work (Rho=0.83, P <0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS-work and WPAI: AS (Rho=0.53, P <0.0001). This pilot study provides not only proof-of-concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms

U2 - https://doi.org/10.1111/all.13177

DO - https://doi.org/10.1111/all.13177

M3 - Article

C2 - 28387952

SN - 0105-4538

VL - 72

SP - 1475

EP - 1484

JO - Allergy

JF - Allergy

IS - 10

ER -